Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu-Ying Pei

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Expert Review of Clinical Immunology|April 10, 2024
The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantationXu-Ying Pei, Xiao-Jun Huang
The Lancet. Haematology|December 1, 2022
Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directionsYing-Jun Chang, Xu-Ying Pei, Xiao-Jun Huang
Bone Marrow Transplantation|January 17, 2018
Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantationMing-Rui Huo, Xu-Ying Pei, Dan Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2019
First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)-specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell TransplantationXiang-Yu Zhao, Xu-Ying Pei, Ying-Jun Chang, et al.
The Journal of Infectious Diseases|October 14, 2017
Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for CytomegalovirusXu-Ying Pei, Xiang-Yu Zhao, Ying-Jun Chang, et al.
Journal of Zhejiang University. Science. B|September 15, 2015
Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 yearsJi-min Shi, Xu-ying Pei, Yi Luo, et al.
American Journal of Hematology|March 16, 2022
Adoptive therapy with cytomegalovirus-specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacyXu-Ying Pei, Xiang-Yu Zhao, Xue-Fei Liu, et al.
Frontiers in Medicine|August 25, 2025
Viral enteritis after allogeneic hematopoietic stem cell transplantation: pathogens, clinical characteristics, and outcomesHai-Lu Sun, Xiang-Yu Zhao, Xiao-Dong Mo, et al.
Transplantation and Cellular Therapy|August 27, 2025
Long-term efficacy of EBV-specific T cells for EBV-PTLD after allogeneic stem cell transplantation: a real word studyHai-Lu Sun, Qiang Fu, Xiang- Yu Zhao, et al.
Cell Death and Differentiation|January 28, 2026
Parvovirus B19 targets hematopoietic stem cells to disrupt multilineage differentiation and drive pancytopeniaXu-Ying Pei, Zhuo-Jun Liu, Qiang Fu, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Expert Review of Clinical Immunology|April 10, 2024
The role of immune reconstitution in relapse after allogeneic hematopoietic stem cell transplantationXu-Ying Pei, Xiao-Jun Huang
The Lancet. Haematology|December 1, 2022
Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directionsYing-Jun Chang, Xu-Ying Pei, Xiao-Jun Huang
Bone Marrow Transplantation|January 17, 2018
Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantationMing-Rui Huo, Xu-Ying Pei, Dan Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2019
First-line Therapy With Donor-derived Human Cytomegalovirus (HCMV)-specific T Cells Reduces Persistent HCMV Infection by Promoting Antiviral Immunity After Allogenic Stem Cell TransplantationXiang-Yu Zhao, Xu-Ying Pei, Ying-Jun Chang, et al.
The Journal of Infectious Diseases|October 14, 2017
Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for CytomegalovirusXu-Ying Pei, Xiang-Yu Zhao, Ying-Jun Chang, et al.
Journal of Zhejiang University. Science. B|September 15, 2015
Invasive fungal infection in allogeneic hematopoietic stem cell transplant recipients: single center experiences of 12 yearsJi-min Shi, Xu-ying Pei, Yi Luo, et al.
American Journal of Hematology|March 16, 2022
Adoptive therapy with cytomegalovirus-specific T cells for cytomegalovirus infection after haploidentical stem cell transplantation and factors affecting efficacyXu-Ying Pei, Xiang-Yu Zhao, Xue-Fei Liu, et al.
Frontiers in Medicine|August 25, 2025
Viral enteritis after allogeneic hematopoietic stem cell transplantation: pathogens, clinical characteristics, and outcomesHai-Lu Sun, Xiang-Yu Zhao, Xiao-Dong Mo, et al.
Transplantation and Cellular Therapy|August 27, 2025
Long-term efficacy of EBV-specific T cells for EBV-PTLD after allogeneic stem cell transplantation: a real word studyHai-Lu Sun, Qiang Fu, Xiang- Yu Zhao, et al.
Cell Death and Differentiation|January 28, 2026
Parvovirus B19 targets hematopoietic stem cells to disrupt multilineage differentiation and drive pancytopeniaXu-Ying Pei, Zhuo-Jun Liu, Qiang Fu, et al.
Pageof 2